ADC Therapeutics (ADCT) Exchange Rate Effect (2020 - 2026)
ADC Therapeutics (ADCT) posted quarterly Exchange Rate Effect of -$5000.0 for Q1 2026, down 103.11% year-on-year from $161000.0 in Q1 2025, and up 80.0% on a QoQ basis from -$25000.0 in Q4 2025.
ADC Therapeutics (ADCT) Exchange Rate Effect (2020 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Exchange Rate Effect for 7 consecutive years, with -$5000.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 103.11% year-over-year to -$5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139000.0 (up 14.88% YoY) and the FY2025 annual result came in at $305000.0, up 467.47% from the prior year.
- Exchange Rate Effect climbed to -$5000.0 in Q1 2026 per ADCT's latest filing, from -$25000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for ADCT reached as high as $291000.0 in Q3 2024 and fell as low as -$343000.0 in Q4 2024.
- A 5-year average of $11352.9 and a median of $6000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 1066.67% — and 2025, when it jumped 1258.33%.
- Year by year, Exchange Rate Effect stood at $243000.0 in 2022, then sank by 37.45% to $152000.0 in 2023, then plunged by 325.66% to -$343000.0 in 2024, then soared by 92.71% to -$25000.0 in 2025, then soared by 80.0% to -$5000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$5000.0, -$25000.0, and $6000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |